Why we changed our mind, in writing.
Bulletins are long-form notes from this practice on changes to our care, errors we have made, and the reasoning behind significant revisions to a monograph. They are slower than a blog. They are longer than a press release. They are the sort of thing you would want to read after the first appointment.
On aspirin for primary prevention, and the friction between BNF and USPSTF.
When two careful bodies disagree, you owe the patient the disagreement, in their own language. We rewrote our hypertension intake script in February. This is what changed and why.
CCH-001PREVENTIONBNFUSPSTFBuprenorphine after the X-waiver: what the deregulation actually changed for our intake.
The Mainstreaming Addiction Treatment Act of 2023 removed the DEA X-waiver for buprenorphine prescribing. Three years on, here is what we actually changed at the front desk, on the second business day after the rule went live.
CCH-003MOUDBUPRENORPHINEINTAKEMenopause hormone therapy: rewriting an intake we got wrong for ten years.
A reading of the 2022 Menopause Society position statement, the cohort we belonged to in residency, and the apology we owe a small set of patients whose perimenopausal symptoms we under-treated for years.
CCH-004PERIMENOPAUSEHRTERRATUMOn Wadar, errata, and the discipline of public correction.
Why a Dutch hydrographic back-end going live on December 5, 2025 reminded us why we publish corrections at all. A short essay on Rijkswaterstaat, library catalogs, and how a small primary-care practice gets to be wrong out loud.
PRACTICEMETHODERRATA